| 33875611
|
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. |
J Immunother Cancer |
2021 |
Beasley GM;Nair SK;Farrow NE;Landa K;Selim MA;Wiggs CA;Jung SH;Bigner DD;True Kelly A;Gromeier M;Salama AK |
View
More |
| 34277838
|
Current status of intralesional agents in treatment of malignant melanoma. |
Ann Transl Med |
2021 |
Zawit M;Swami U;Awada H;Arnouk J;Milhem M;Zakharia Y |
View
More |
| 37313455
|
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses. |
Mol Ther Oncolytics |
2023 |
Webb MJ;Kottke T;Kendall BL;Swanson J;Uzendu C;Tonne J;Thompson J;Metko M;Moore M;Borad M;Roberts L;Diaz RM;Olin M;Borgatti A;Vile R |
View
More |
